Condition: Thyroid Carcinoma · Pediatric Cancer · Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
This study aims to define the optimal surveillance strategy for children exposed to radiotherapy by assessing the incidence, risk factors, and timing of thyroid nodules and differentiated thyroid cancer. It also investigates the genetic features of thyroid tumors in this population to identify predictive biomarkers of onset, malignancy, and aggressiveness. Ultimately, the goal is to support more personalized management, including tailored surgery and targeted therapies.
This description comes directly from the study's public registry record.
Federico Baronio · 00390512144816 · federico.baronio@aosp.bo.it
Always discuss trial participation with your own doctor first.
| UO Medicina Nucleare - IRCCS Azienda Ospedaliero-Universitaria di Bologna | Bologna, Italy | Recruiting |
| UOC Pediatria - IRCCS Azienda Ospedaliero-Universitaria di Bologna | Bologna, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07473518